Lensar Abandons Alcon Acquisition Due to FTC Scrutiny

Lensar has terminated its planned acquisition by Alcon due to unresolved regulatory concerns from the US Federal Trade Commission. Despite initial expectations for a mid-to-late 2025 closing, the deal remained pending for nearly a year. Both companies will retain a $10m deposit, and Lensar president and CEO Nick Curtis said the company remains committed to advancing the field of cataract surgery through its ALLY robotic cataract laser system.